<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Alzheimer_disease</id>
	<title>Alzheimer disease - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://idwiki.org/index.php?action=history&amp;feed=atom&amp;title=Alzheimer_disease"/>
	<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Alzheimer_disease&amp;action=history"/>
	<updated>2026-05-13T00:53:40Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://idwiki.org/index.php?title=Alzheimer_disease&amp;diff=4976&amp;oldid=prev</id>
		<title>Aidan: Text replacement - &quot;Clinical Presentation&quot; to &quot;Clinical Manifestations&quot;</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Alzheimer_disease&amp;diff=4976&amp;oldid=prev"/>
		<updated>2020-07-16T07:14:40Z</updated>

		<summary type="html">&lt;p&gt;Text replacement - &amp;quot;Clinical Presentation&amp;quot; to &amp;quot;Clinical Manifestations&amp;quot;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Revision as of 07:14, 16 July 2020&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 17:&lt;/td&gt;
  &lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 17:&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Gene mutations: APP, PS-1, PS-2, and Apo epsilon-4&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* Gene mutations: APP, PS-1, PS-2, and Apo epsilon-4&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Presentation&lt;/del&gt; ==&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Clinical &lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;Manifestations&lt;/ins&gt; ==&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br /&gt;&lt;/td&gt;
&lt;/tr&gt;
&lt;tr&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* History&lt;/div&gt;&lt;/td&gt;
  &lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;
  &lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;* History&lt;/div&gt;&lt;/td&gt;
&lt;/tr&gt;

&lt;!-- diff cache key site7_mediawiki:diff:1.41:old-4081:rev-4976:wikidiff2=table:1.13.0:bc2a06be --&gt;
&lt;/table&gt;</summary>
		<author><name>Aidan</name></author>
	</entry>
	<entry>
		<id>https://idwiki.org/index.php?title=Alzheimer_disease&amp;diff=4081&amp;oldid=prev</id>
		<title>Maintenance script: Imported from text file</title>
		<link rel="alternate" type="text/html" href="https://idwiki.org/index.php?title=Alzheimer_disease&amp;diff=4081&amp;oldid=prev"/>
		<updated>2020-07-04T01:17:22Z</updated>

		<summary type="html">&lt;p&gt;Imported from text file&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;== Pathophysiology ==&lt;br /&gt;
&lt;br /&gt;
* Build-up of beta amyloid plaques with neurofibrillary tangles&lt;br /&gt;
* Degeneration of the transentorhinal region, followed by hippocampus then lateral and posterior temporal and parietal neocortex&lt;br /&gt;
&lt;br /&gt;
== Differential Diagnosis ==&lt;br /&gt;
&lt;br /&gt;
* See [[Dementia.md|Dementia]]&lt;br /&gt;
&lt;br /&gt;
== Epidemiology ==&lt;br /&gt;
&lt;br /&gt;
* Most prevalent dementia syndrome&lt;br /&gt;
&lt;br /&gt;
== Risk Factors ==&lt;br /&gt;
&lt;br /&gt;
* Age&lt;br /&gt;
* Gene mutations: APP, PS-1, PS-2, and Apo epsilon-4&lt;br /&gt;
&lt;br /&gt;
== Clinical Presentation ==&lt;br /&gt;
&lt;br /&gt;
* History&lt;br /&gt;
** Typically begins with memory loss&lt;br /&gt;
** Later, aphasia and navigational problems&lt;br /&gt;
* Signs &amp;amp;amp; Symptoms&lt;br /&gt;
&lt;br /&gt;
== Management ==&lt;br /&gt;
&lt;br /&gt;
=== Symptomatic Treatments ===&lt;br /&gt;
&lt;br /&gt;
* Cholinesterase inhibitors for AD with stroke, and as an option for Parkinson disease dementia&lt;br /&gt;
** Not indicated in vascular dementia&lt;br /&gt;
** No specific preferred cholinesterase inhibitor&lt;br /&gt;
** Modest improvements in cognition but does not delay nursing home&lt;br /&gt;
** Side effects include bradycardia, syncope, GI intolerance, urinary incontinence, and abnormal dreams&lt;br /&gt;
*** NMS and rhabdomyolysis are rare but reported&lt;br /&gt;
* Combination with memantine appears safe&lt;br /&gt;
** Can either add memantine to cholinesterase inhibitor, or replace it&lt;br /&gt;
* Trial of antidepressent can be considered in patients with depression, severe dysthymia, or emotional lability&lt;br /&gt;
* Antipsychotics should be reserved for cases where the patient&amp;#039;s agitated causes a risk of harm to themselves or others&lt;br /&gt;
&lt;br /&gt;
=== Discontinuation of Acetylcholinesterase Inhibitors ===&lt;br /&gt;
&lt;br /&gt;
* May worsen cognition, but should be considered if there are adverse side effects, or the dementia has progressed past the point where they would be helpful&lt;br /&gt;
* If stopped for non-effectiveness, they should be tapered before stopping, then monitored for cognitive decline&lt;br /&gt;
&lt;br /&gt;
== Further Reading ==&lt;br /&gt;
&lt;br /&gt;
* [http://dx.doi.org/10.5770/cgj.15.49 Canadian Dementia Guidelines CCCDTD4 2012]&lt;br /&gt;
&lt;br /&gt;
[[Category:Neurology]]&lt;br /&gt;
[[Category:Geriatrics]]&lt;/div&gt;</summary>
		<author><name>Maintenance script</name></author>
	</entry>
</feed>